Guobin Kang
Impact in
- Virology top 2%
- HIV Research and Treatment
Papers in
- Co-authors
- Qingsheng Li (23 shared papers)Wuxun Lu (10 shared papers)Charles A. Wood (11 shared papers)You Zhou (5 shared papers)Zhe Yuan (6 shared papers)Christopher J. Destache (5 shared papers)Junfeng Zhang (1 shared paper)Hadiza I. Galadima (1 shared paper)
- Journals
- Journal of Virology (4 papers)PLoS ONE (3 papers)Frontiers in Oncology (2 papers)The Journal of Immunology (2 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)
- Partner nations
- United StatesChinaZambia
In The Last Decade
Guobin Kang
39 papers receiving 892 citations
Peers
Comparison fields: 5 of 54
- Virology 429
- Drug Discovery 4
- Biomaterials 90
- Pharmaceutical Science 47
- Immunology 95
Countries citing papers authored by Guobin Kang
This map shows the geographic impact of Guobin Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobin Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobin Kang more than expected).
Fields of papers citing papers by Guobin Kang
This network shows the impact of papers produced by Guobin Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobin Kang. The network helps show where Guobin Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guobin Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 152 | |
| 2 | 2014 | 85 | |
| 3 | 2012 | 64 | |
| 4 | 2016 | 42 | |
| 5 | 2018 | 41 | |
| 6 | 2017 | 40 | |
| 7 | 2018 | 39 | |
| 8 | 2018 | 38 | |
| 9 | 2016 | 35 | |
| 10 | 2014 | 32 | |
| 11 | 2016 | 32 | |
| 12 | 2016 | 28 | |
| 13 | 2016 | 27 | |
| 14 | 2015 | 21 | |
| 15 | 2018 | 17 | |
| 16 | 2015 | 16 | |
| 17 | 2022 | 16 | |
| 18 | 2015 | 15 | |
| 19 | 2014 | 14 | |
| 20 | 2018 | 14 |
About Guobin Kang
Guobin Kang is a scholar working on Virology, Oncology, Infectious Diseases, Immunology and Cardiology and Cardiovascular Medicine, having authored 40 papers that have together received 899 indexed citations. Recurring topics across this work include HIV Research and Treatment (22 papers), Viral-associated cancers and disorders (5 papers), HIV/AIDS drug development and treatment (4 papers), HIV/AIDS Research and Interventions (3 papers), Nanoparticle-Based Drug Delivery (2 papers), T-cell and B-cell Immunology (2 papers), Viral Infections and Immunology Research (2 papers) and Ocular Oncology and Treatments (1 paper). The work is most often cited by research in Virology (429 citations), Drug Discovery (4 citations), Biomaterials (90 citations), Pharmaceutical Science (47 citations) and Immunology (95 citations). Guobin Kang has collaborated with scholars based in United States, China and Zambia. Frequent co-authors include Qingsheng Li, Wuxun Lu, Charles A. Wood, You Zhou, Zhe Yuan, Christopher J. Destache, Junfeng Zhang, Hadiza I. Galadima, Subhra Mandal and Pavan Kumar Prathipati. Their work appears in journals such as Journal of Virology, PLoS ONE, Frontiers in Oncology, The Journal of Immunology and JAIDS Journal of Acquired Immune Deficiency Syndromes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.